Singular Genomics Systems (NASDAQ:OMIC) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.41) by 19.51 percent. This is a 32 percent decrease over losses of $(0.25) per share from the same period last year.
AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
AstraZeneca Plc (NASDAQ:AZN) has filed suit against former VP and head of investor relations Chris Sheldon as he prepares…